🇺🇸 FDA
Pipeline program

PEG-somatropin

GenSci 004 CT-Zhejiang

Approved mab active

Quick answer

PEG-somatropin for Growth Hormone Deficiency is a Approved program (mab) at China SXT Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Growth Hormone Deficiency
Phase
Approved
Modality
mab
Status
active

Clinical trials